Research in the Area of Monoclonal Antibodies Reported from Erasmus University Medical Center (DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing...).

Předmět:	MONOCLONAL antibodies ACADEMIC medical centers HEALTH facilities RESEARCH protocols
Zdroj:	Immunotherapy Weekly; 7/11/2023, p1644-1644, 1p
Abstrakt:	Drugs and Therapies, Emicizumab Therapy, Health and Medicine, Immunologic Agents, Immunotherapy, Monoclonal Antibodies, Pharmaceuticals, Pharmacokinetics, Pharmacology Keywords: Drugs and Therapies; Emicizumab Therapy; Health and Medicine; Immunologic Agents; Immunotherapy; Monoclonal Antibodies; Pharmaceuticals; Pharmacokinetics; Pharmacology EN Drugs and Therapies Emicizumab Therapy Health and Medicine Immunologic Agents Immunotherapy Monoclonal Antibodies Pharmaceuticals Pharmacokinetics Pharmacology 1644 1644 1 07/10/23 20230711 NES 230711 2023 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Current study results on monoclonal antibodies have been published. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu